Retractable Technologies (NYSE:RVP) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a report issued on Monday morning. The firm issued a hold rating on the stock.

Retractable Technologies Stock Performance

NYSE:RVP opened at $0.72 on Monday. The stock has a market cap of $21.45 million, a P/E ratio of -1.17 and a beta of 2.06. The company has a current ratio of 9.51, a quick ratio of 6.54 and a debt-to-equity ratio of 0.01. The stock’s 50-day moving average is $0.79 and its 200-day moving average is $0.97. Retractable Technologies has a 1-year low of $0.70 and a 1-year high of $1.34.

Retractable Technologies (NYSE:RVP) last released its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%. The firm had revenue of $6.03 million for the quarter.

Insider Activity at Retractable Technologies

In related news, CEO Thomas J. Shaw bought 71,422 shares of Retractable Technologies stock in a transaction that occurred on Friday, September 20th. The shares were acquired at an average cost of $0.82 per share, for a total transaction of $58,566.04. Following the completion of the acquisition, the chief executive officer now directly owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. The trade was a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders have purchased 176,179 shares of company stock worth $144,814 over the last ninety days. Insiders own 55.00% of the company’s stock.

Hedge Funds Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies as of its most recent filing with the SEC. 7.58% of the stock is currently owned by institutional investors and hedge funds.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.